The 10-second takeaway
For the quarter ended Sep. 30 (Q3), Ceradyne missed estimates on revenues and missed expectations on earnings per share.
Compared to the prior-year quarter, revenue contracted significantly and GAAP earnings per share dropped to a loss.
Margins dropped across the board.
Ceradyne reported revenue of $106.2 million. The five analysts polled by S&P Capital IQ looked for a top line of $116.2 million on the same basis. GAAP reported sales were 28% lower than the prior-year quarter's $148.0 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $0.00. The four earnings estimates compiled by S&P Capital IQ predicted $0.24 per share. GAAP EPS were -$0.96 for Q3 compared to $0.82 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 28.6%, 770 basis points worse than the prior-year quarter. Operating margin was 7.3%, 1,400 basis points worse than the prior-year quarter. Net margin was -21.7%, 3,550 basis points worse than the prior-year quarter.
Next quarter's average estimate for revenue is $123.6 million. On the bottom line, the average EPS estimate is $0.28.
Next year's average estimate for revenue is $476.7 million. The average EPS estimate is $0.98.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 1,205 members out of 1,245 rating the stock outperform, and 40 members rating it underperform. Among 338 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 326 give Ceradyne a green thumbs-up, and 12 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Ceradyne is hold, with an average price target of $23.40.
- Add Ceradyne to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no positions in the stocks mentioned above. Motley Fool newsletter services recommend Ceradyne. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.